Most of what's "known" comes from: Preclinical work (animal/cell) exploring repair pathways, inflammation signaling, and vascular changes Limited human observations focused more on recovery and discomfort than on body fat change So, when someone searches for BPC 157 weight loss , it's essential to set expectations: this isn't like clinically validated obesity therapies that have decades of outcome data, standardized dosing, and predictable effects on appetite and metabolic pathwayssuch as FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound)
How semaglutide causes nausea in the first place Understanding why semaglutide makes people nauseous requires looking at two separate mechanisms working simultaneously
Care 42 , 15931603 (2019)
Studies have shown that p53/TIGAR mediates the inhibition of mitophagy
Changes in GH appear to be consistent, with several studies reporting increased GH levels following surgery (9294), whereas the response of total IGF-I to bariatric surgery is more variable (117)
